Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Late Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07434518
What this trial is testing

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Ended earlyNCT00351039
What this trial is testing

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543172
What this trial is testing

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
Roswell Park Cancer Institute 29
Testing effectiveness (Phase 2)Study completedNCT01556191
What this trial is testing

Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

Who this might be right for
Stage IV Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 379
Large-scale testing (Phase 3)UnknownNCT04874844
What this trial is testing

JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety

Who this might be right for
NSCLC
Beijing Dongfang Biotech Co., Ltd. 420
Testing effectiveness (Phase 2)UnknownNCT00278187
What this trial is testing

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT05270395
What this trial is testing

Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation

Who this might be right for
Lung Cancer
Laurie McLouth 75
Post-approval studies (Phase 4)Study completedNCT01317615
What this trial is testing

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

Who this might be right for
Carcinoma, Large CellNeuroendocrine Tumors
Novartis Pharmaceuticals 49
Not applicableNot Yet RecruitingNCT05621902
What this trial is testing

Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

Who this might be right for
Lung Cancer
Mats Lambe 398
Early research (Phase 1)Ended earlyNCT03057314
What this trial is testing

Improving Function,Welfare of Late-stage Cancer Subjects by ACC

Who this might be right for
Solid Malignancies, With or Without Lung Metastases
Amorphical Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Very early researchStudy completedNCT00884520
What this trial is testing

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Who this might be right for
Lung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more
Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)UnknownNCT01955421
What this trial is testing

Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc

Who this might be right for
Advanced Stage Non Small Cell Lung Cancer
Sun Yat-sen University 224
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Early research (Phase 1)Study completedNCT04314089
What this trial is testing

Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)

Who this might be right for
Non-small Cell Lung Cancer
Edward Patz 31
Early research (Phase 1)WithdrawnNCT01799161
What this trial is testing

Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNon-small-cell Lung CarcinomaLung Cancer+1 more
Eckhard Podack
Testing effectiveness (Phase 2)UnknownNCT03574402
What this trial is testing

Phase II Umbrella Study Directed by Next Generation Sequencing

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Guangdong Association of Clinical Trials 400
Testing effectiveness (Phase 2)Study completedNCT00473083
What this trial is testing

Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer

Who this might be right for
Rash
British Columbia Cancer Agency 150
Not applicableUnknownNCT04455984
What this trial is testing

Multimodality Treatment Including Curative Resection of Advanced NSCLC

Who this might be right for
Advanced Non-small-cell Lung Cancer
Medical University of Vienna 190
Large-scale testing (Phase 3)UnknownNCT03884192
What this trial is testing

Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small Cell Lung
Shandong Cancer Hospital and Institute 162
Next Page